Senior Director Market Access Inline Immunoglobulins (IG)

Senior Director of Market Access for Inline Assets

The Senior Director of Market Access for Inline Assets will be responsible for shaping and implementing market access strategies for CSL Behring inline assets. This role is accountable for maximizing the asset total life cycle value throughout product life cycle. It requires strong expertise in obtaining, sustaining, and optimizing product pricing & reimbursement, and a comprehensive understanding of the payer environment in key international markets.

Key Responsibilities:

• Lead the Market Access inline team in one Therapeutic Areas (TAs). Build, mentor, and lead a high-performing global market access inline team, fostering a culture of collaboration, innovation, inclusion, and accountability.
• Serve as a key member of the global Market Access Leadership Team (MALT), contributing to the development and execution of functional strategy, operations, and capability building.
• Accountable for Market Access deliverables during the inline phase, continuously refining and improving standards for these deliverables.
• Collaborate with Medical Affairs, Marketing, and other partner functions to influence brand strategy and execution, ensuring proper integration of market access considerations.
• Keep abreast with payer policies and regulations, economic data within the assigned TA in key international markets. Identify market access opportunities and risks, capture opportunities, mitigate risks through proactive planning, scenario analysis, and stakeholder engagement.
• Deliver and periodically update the Global Value Dossier as a foundational document for affiliate Pricing & Reimbursement (P&R) and Health Technology Assessment (HTA) submissions and resubmissions.
• Provide guidance and support to country teams in P&R and HTA submissions, negotiations, and authority responses, ensuring alignment with global strategies. Optimize payer value propositions (PVPs) and health economic models to effectively communicate the clinical and economic value of inline assets to payers and other key stakeholders.
• Continuously drive the development of lifecycle payer evidence and optimize pricing strategies to maintain and enhance P&R throughout the product lifecycle.
• Provide systematic market access insights for forecasting and long-range planning, including analysis of key payer policy changes, risk assessments, and opportunity identification.
• Represent CSL at global trade associations, participating in access-related committees and working groups to influence industry standards and practices.

Qualifications:

• At least 12 years of experience in market access, with significant exposure to diverse healthcare systems in the international markets.
• Proven track record of leading and developing high-performing teams in a global, crossfunctional environment. A role model of collaboration, innovation, inclusion, and accountability.
• Proven track record in obtaining, sustaining, and optimizing pricing, reimbursement, and patient access across diverse healthcare systems in international markets.
• Extensive knowledge of global healthcare systems, payer landscapes, and the interplay between market access and international markets.
• Proven ability to deliver superior performance across diverse healthcare systems in the international markets.
• An advanced degree in Health Economics, Public Health, or a related field is required.

About CSL Vifor

CSL Vifor is a global partner of choice for pharmaceuticals and innovative, leading therapies in iron deficiency and nephrology. We specialize in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision healthcare, aiming to help patients around the world lead better, healthier lives. Headquartered in St. Gallen, Switzerland, CSL Vifor also includes the joint company Vifor Fresenius Medical Care Renal Pharma (with Fresenius Medical Care). The parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people and delivers its lifesaving therapies to people in more than 100 countries.